Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,395 public trials 842 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

NCT01478685

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +49 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 13 locations
View Trial Details
Completed

Post-Gastric Bypass Hypoglycemia

NCT01933490

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +8 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

NCT02021500

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • TGen Clinical Research Services Scottsdale, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Pacific Shores Medical Group Long Beach, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 39 locations
View Trial Details
Completed

Telavancin Pharmacokinetics in Cystic Fibrosis Patients

NCT03172793

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Hartford Hospital Hartford, Connecticut, United States
  • IU Health University Hospital Indianapolis, Indiana, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • St. Christophers Hospital for Children Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study to Evaluate the Effect of VX-661 in Combination With Ivacaftor on Chest Imaging Endpoints in Subjects With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation

NCT02730208

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Chermside, Australia
  • Melbourne, Australia
  • Nedlands, Australia
  • New Lambton Heights, Australia
View Trial Details

Related conditions